Maravai Lifesciences Holdings Income Statement (2020-2026) | MRVI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	217.78M	204.81M	228.44M	244.29M	242.73M	191.26M	204.71M	79.03M	68.91M	66.86M	74.14M	64.18M	69.42M	69.03M	56.56M	46.85M	47.40M	41.63M	49.87M	65.84M
Cost of Revenue (Quarter)	37.81M	32.22M	39.14M	40.03M	37.50M	38.18M	53.25M	33.68M	43.27M	36.69M	35.11M	38.34M	38.58M	36.79M	37.17M	39.12M	39.63M	35.98M	37.02M	32.14M
Gross Profit (Quarter)	179.96M	172.59M	189.31M	204.26M	205.24M	153.09M	151.46M	45.35M	25.64M	30.18M	39.03M	25.84M	30.84M	32.23M	19.39M	7.72M	7.77M	5.66M	12.84M	33.70M
Operating items
Research & Development (Quarter)	1.93M	1.95M	9.18M	3.69M	4.27M	5.39M	5.01M	4.14M	4.19M	4.35M	4.59M	5.03M	4.92M	4.70M	4.56M	4.89M	4.88M	3.84M	3.79M	3.89M
Selling, General & Administrative (Quarter)	24.50M	26.51M	25.58M	33.20M	28.06M	30.80M	37.20M	38.67M	35.38M	38.86M	38.48M	40.88M	40.56M	39.09M	41.24M	39.56M	38.58M	35.40M	31.58M	29.09M
Restructuring Costs (Quarter)											6.47M	-1.21M	-0.00M	-0.00M	0.01M			7.39M	10.44M	2.88M
Other Operating Expenses (Quarter)	37.81M	11.25M		40.03M	29.70M			33.68M	40.96M	39.07M	-116.99M	38.34M	37.39M	154.06M	11.28M	12.44M	70.22M	0.06M	25.82M
Operating Expenses (Quarter)	64.24M	49.43M	73.90M	76.93M	62.03M	74.36M	95.47M	76.49M	80.53M	82.28M	-67.45M	83.04M	82.86M	197.85M	57.09M	56.89M	113.67M	46.69M	71.64M	35.86M
Operating Income (Quarter)	153.53M	155.38M	154.54M	167.37M	180.70M	116.90M	109.25M	2.53M	-11.61M	-15.42M	-7.15M	-18.86M	-13.44M	-165.61M	-37.70M	-49.16M	-66.28M	-41.03M	-58.80M	-2.16M
EBIT (Quarter)	153.53M	155.38M	154.54M	167.37M	180.70M	116.90M	109.25M	2.53M	-11.61M	-15.42M	-7.15M	-18.86M	-13.44M	-165.61M	-37.70M	-49.16M	-66.28M	-41.03M	-58.80M	-2.16M
Non-operating items
Interest & Investment Income (Quarter)							2.34M	6.04M	6.79M	7.43M	7.46M	7.21M	7.09M	7.07M	6.04M	3.23M	3.03M	2.80M	2.38M	1.87M
Other Non Operating Income (Quarter)	-0.00M	0.08M	0.20M	-0.20M			1.06M	0.17M	-1.62M	0.07M	1.39M	0.11M	-2.56M	0.07M	-0.80M	0.02M	-4.06M	-0.07M	-0.04M	-0.49M
Net income details
EBT (Quarter)	145.88M	151.02M	144.69M	166.84M	174.99M	113.76M	95.88M	-4.52M	-13.36M	-20.56M	656.19M	-22.41M	-20.86M	-172.14M	-46.07M	-52.69M	-74.12M	-45.15M	-63.01M	-6.53M
Tax Provisions (Quarter)	11.39M	18.84M	17.58M	19.98M	18.27M	14.11M	8.45M	-3.17M	-1.42M	-5.46M	766.17M	0.27M	-2.44M	0.31M	-0.01M	0.16M	-4.29M	-0.09M	0.01M	-0.15M
Profit After Tax (Quarter)	134.50M	132.18M	127.11M	66.86M	71.24M	44.47M	308.09M	-1.35M	-11.94M	-15.10M	-109.98M	-12.08M	-9.79M	-172.46M	-25.91M	-29.95M	-69.84M	-45.06M	36.97M	-6.38M
Income from Non-Controlling Interests (Quarter)	85.35M	78.22M	71.28M	80.00M	85.48M	55.18M	49.80M	-1.28M	-5.40M	-8.64M	-4.02M	-10.60M	-8.63M	-75.38M	-20.16M	-22.91M	-30.25M	-19.50M	-27.33M	-2.64M
Income from Continuing Operations (Quarter)	134.50M	132.18M	127.11M	146.86M	156.72M	99.65M	87.43M	-1.35M	-11.94M	-15.10M	-109.98M	-22.68M	-18.42M	-172.46M	-46.07M	-52.85M	-69.84M	-45.06M	-63.02M	-6.38M
Consolidated Net Income (Quarter)	134.50M	132.18M	127.11M	146.86M	156.72M	99.65M	87.43M	-1.35M	-11.94M	-15.10M	-109.98M	-22.68M	-18.42M	-172.46M	-46.07M	-52.85M	-69.84M	-45.06M	-63.02M	-6.38M
Income towards Parent Company (Quarter)	134.50M	132.18M	127.11M	146.86M	156.72M	99.65M	87.43M	-1.35M	-11.94M	-15.10M	-109.98M	-22.68M	-18.42M	-172.46M	-46.07M	-52.85M	-69.84M	-45.06M	-63.02M	-6.38M
Net Income towards Common Stockholders (Quarter)	134.50M	132.18M	127.11M	146.86M	156.72M	99.65M	87.43M	-1.35M	-11.94M	-15.10M	-109.98M	-22.68M	-18.42M	-172.46M	-46.07M	-52.85M	-69.84M	-45.06M	-63.02M	-6.38M
Additional items
EPS (Basic) (Quarter)	1.20	1.12	1.11	1.12	1.19	0.76	0.66	-0.01	-0.09	-0.11	-0.83	-0.17	-0.14	-1.22	-0.33	-0.37	-0.48	-0.31	-0.44	-0.04
EPS (Diluted) (Quarter)	1.20	0.51	0.49	0.58	0.61	0.76	0.34	-0.01	-0.09	-0.11	-0.83	-0.17	-0.14	-1.22	-0.33	-0.37	-0.48	-0.31	-0.44	-0.04
Shares Outstanding (Quarter)	112.20M	118.43M	114.79M	131.49M	131.52M	131.54M	131.54M	131.74M	131.86M	131.93M	131.92M	132.33M	135.84M	141.56M	137.91M	143.43M	144.24M	144.68M	144.36M	146.43M
Shares Outstanding (Diluted) (Quarter)	112.28M	258.03M	257.80M	255.29M	255.36M	131.65M	255.32M	131.74M	131.86M	131.93M	131.92M	132.33M	135.84M	141.56M	137.91M	143.43M	144.24M	144.68M	144.36M	146.43M
Shares Outstanding (Entity) (Quarter)	112.20M	118.43M	114.79M	131.49M	131.52M	131.54M	131.54M	131.74M	131.86M	131.93M	131.92M	132.33M	135.84M	141.56M	137.91M	143.43M	144.24M	144.68M	144.36M	146.43M
EBITDA (Quarter)	153.53M	155.38M	154.54M	167.37M	180.70M	116.90M	109.25M	2.53M	-11.61M	-15.42M	-7.15M	-18.86M	-13.44M	-165.61M	-37.70M	-49.16M	-66.28M	-41.03M	-58.80M	-2.16M
Interest Expenses (Quarter)	14.42M	14.42M	7.02M	24.43M	24.43M	24.43M	9.96M	26.08M	26.08M	26.08M	15.40M	12.14M	11.94M	25.99M	11.26M	26.13M	26.22M	26.22M	8.22M	6.15M
Tax Rate (Quarter)	7.80%	12.48%	12.15%	11.98%	10.44%	12.40%	8.81%	70.20%	10.63%	26.56%	116.76%	-1.21%	11.68%	-0.18%	0.02%	-0.31%	5.78%	0.20%	-0.01%	2.31%

Research Tools

Developers

Maravai Lifesciences Holdings Income Statement (2020-2026) | MRVI

Research Tools

Developers

Maravai Lifesciences Holdings Income Statement (2020-2026) | MRVI

Create an account

Sign In

Reset Password